Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis. (2017)

First Author: Aarnoutse RE
Attributed to:  Tuberculosis Treatment Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1128/aac.01054-17

PubMed Identifier: 28827417

Publication URI: http://europepmc.org/abstract/MED/28827417

Type: Journal Article/Review

Volume: 61

Parent Publication: Antimicrobial agents and chemotherapy

Issue: 11

ISSN: 0066-4804